Clinical Trial

The Effects of High-dose Vitamin B6 on Depression and Anxiety Symptoms

Recruiting
View on ClinicalTrials.gov →
Summary
This clinical trial investigates the effects of Vitamin B6 supplementation on neural inhibition using electroencephalography (EEG), in relation to depression and anxiety symptoms in participants from the general population with a relatively high level of symptoms at baseline. Researchers will compare a placebo group to high-dose Vitamin B6 to test the hypothesis that Vitamin B6 moves the excitation/inhibition balance towards inhibition.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-03-09; most recent amendment 2026-04-27.
Trial Details
NCT Number NCT07469462
Lead Sponsor University of Reading
Collaborators: eBeauty Ltd Innopure, Regus House, Cardiff Gate Business Park, Malthouse Avenue, Cardiff, CF23 8RU
Conditions Neural Inhibition, Anxiety, Depression
Enrollment 44 participants
Start Date 2026-05-01
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-04-28